EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatic Fibrosis and Liver Cancer

Aina Anton, Scott L Friedman, Bruno Cogliati

Seminars in Liver Disease · 2026-03 · 46 (01) · 031-050

DOI: 10.1055/a-2779-4937 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 13.01.2026. Verfasst von Aina Anton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomè…. Hauptthemen laut MEDLINE: Liver Neoplasms, Liver Cirrhosis, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: São Paulo Research Foundation (FAPESP), NIDDK NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer, or hepatocellular carcinoma (HCC), typically emerges in fibrotic livers where persistent inflammation and extracellular matrix (ECM) remodeling create a permissive niche for malignant transformation. Although cirrhosis remains a major risk factor, mounting data show that fibrosis itself, often in the context of metabolic dysfunction-associated steatotic liver disease (MASLD), can promote hepatocarcinogenesis even before cirrhosis develops. This review synthesizes mechanistic insights from hepatic stellate cell (HSC) biology and tumor immunology that position fibrosis as an instigator of HCC. Fibrotic remodeling increases ECM stiffness, distorts sinusoidal architecture, and promotes abnormal angiogenesis, while HSCs reprogram immune surveillance toward immune cell exclusion and immunosuppression. Aging and cellular senescence amplify these effects through a senescence-associated secretory phenotype in HSCs and hepatocytes, which fuels chronic inflammation and immune dysfunction. Metabolic crosstalk and extracellular vesicle exchange further couple stromal and epithelial programs, reinforcing stemness, therapy resistance, and metastatic fitness. In conclusion, the convergence of fibrogenic and oncogenic signaling drives HCC, uncovering actionable targets for its prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsLiver CirrhosisCarcinoma, HepatocellularHumansHepatic Stellate CellsAnimalsExtracellular MatrixSignal TransductionCellular SenescenceTumor Microenvironment

Autor:innen und Institutionen

  • Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica…
  • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Mount Sinai Institute for Liver Research, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Department of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, SP, Brazil.

Förderung

  • São Paulo Research Foundation (FAPESP)
  • NIDDK NIH HHS
  • NIDDK

Zitieren

APA

Anton, A., Friedman, S. L., & Cogliati, B. (2026). Hepatic Fibrosis and Liver Cancer. Seminars in Liver Disease, 46(01), 031-050. https://doi.org/10.1055/a-2779-4937

Vancouver

Anton A, Friedman SL, Cogliati B. Hepatic Fibrosis and Liver Cancer. Seminars in Liver Disease. 2026;46(01):031-050. doi:10.1055/a-2779-4937

BibTeX
@article{Anton2026,
  author = {Anton, Aina and Friedman, Scott L and Cogliati, Bruno},
  title = {Hepatic Fibrosis and Liver Cancer},
  journal = {Seminars in Liver Disease},
  year = {2026},
  volume = {46},
  number = {01},
  pages = {031--050},
  doi = {10.1055/a-2779-4937}
}
Kostenlos starten →